Cormorant Asset Management, LP - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q2 2022$1,015,000
-17.9%
50,0000.0%0.08%
-18.9%
Q1 2022$1,237,000
-64.4%
50,000
-50.0%
0.10%
-54.1%
Q4 2021$3,475,000
-66.7%
100,000
-74.0%
0.21%
-51.2%
Q3 2021$10,443,000
+4.6%
385,0810.0%0.42%
+25.1%
Q2 2021$9,985,000
-28.7%
385,081
-40.8%
0.34%
+8.7%
Q1 2021$14,008,000
+0.2%
650,0000.0%0.31%
-6.3%
Q4 2020$13,975,000
+45.8%
650,0000.0%0.33%
-9.8%
Q3 2020$9,588,000
-51.6%
650,000
-26.6%
0.37%
-51.1%
Q2 2020$19,790,000
+26.4%
885,838
-20.0%
0.76%
+3.9%
Q1 2020$15,655,000
+164.0%
1,107,900
+203.5%
0.73%
+206.8%
Q4 2019$5,931,000
-71.3%
365,000
-38.3%
0.24%
-81.2%
Q3 2019$20,686,000
-47.6%
591,200
-15.5%
1.26%
-44.5%
Q2 2019$39,494,000
-41.2%
700,000
-23.9%
2.27%
-50.1%
Q1 2019$67,206,000
-4.7%
920,000
-16.8%
4.54%
-20.7%
Q4 2018$70,523,000
-37.7%
1,105,557
-2.6%
5.73%
-22.2%
Q3 2018$113,239,000
+29.2%
1,135,000
-8.0%
7.36%
+13.5%
Q2 2018$87,622,000
-31.7%
1,233,4220.0%6.48%
-32.2%
Q1 2018$128,375,000
-8.1%
1,233,422
-11.0%
9.57%
-34.5%
Q4 2017$139,647,000
+299.6%
1,386,485
+38.6%
14.62%
+136.9%
Q3 2017$34,950,000
+82.7%
1,000,000
+25.1%
6.17%
+94.6%
Q2 2017$19,131,000
-23.0%
799,469
-10.7%
3.17%
-12.1%
Q1 2017$24,854,000895,6263.61%
Other shareholders
ANAPTYSBIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders